Back to Journals » Neuropsychiatric Disease and Treatment » Volume 21

Propionic Acid-Producing Bacteria as Provocateurs of Anxiety and Depression? [Letter]

Authors Prescott SL , Logan AC 

Received 8 January 2025

Accepted for publication 4 February 2025

Published 6 February 2025 Volume 2025:21 Pages 257—258

DOI https://doi.org/10.2147/NDT.S516386

Checked for plagiarism Yes

Editor who approved publication: Dr Yu-Ping Ning



Susan L Prescott,1–3,* Alan C Logan3,*

1School of Medicine, University of Western Australia, Perth, WA, Australia; 2Department of Family and Community Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; 3Nova Institute for Health, Baltimore, MD, 21231, USA

*These authors contributed equally to this work

Correspondence: Alan C Logan, Nova Institute for Health, 1407 Fleet Street, Baltimore, MD, 21231, USA, Email [email protected]


View the original paper by Dr Zhao and colleagues


Dear editor

In a recent study published by Zhao et al, the authors made an important contribution to the complex discourse surrounding the comorbidity of irritable bowel syndrome (IBS) and mental disorders.1 In particular, the authors discovered significant and positive relationships between Patient Health Questionnaire-9 (PHQ-9) scores and an abundance of Monoglobus and Lachnoclostridium spp. They also linked Subdoligranulum and Holdemanella genera to abundances to Generalized Anxiety Disorder 7-Item (GAD-7) scores. Given that Lachnoclostridium spp. are generally recognized as pro-inflammatory gut microbiota, the authors focused their mechanistic discussions on Lachnoclostridium, and concluded their study by pointing toward the species as a potential marker of IBS.

We agree with the arguments made by Zhao et al and are hopeful that their efforts will be widely disseminated and used as a roadmap for investigators to follow. Here, we would like to add one mechanistic pathway that was not considered by the authors. Notably, Lachnoclostridium, and Subdoligranulum have one important feature in common—they are associated with a more abundant pool of propionic acid. Elevations in propionic acid, in turn, contribute to the growth of Monoglobus, the genera that Zhao et al linked to depression. Although short-chain fatty acids are often painted with same universally-beneficial brush, there is ample evidence to demonstrate an undesirable side of propionic acid, an aspect that can potentially explain the findings of Zhao et al.

First, elevated levels of fecal and blood propionic acid have been noted in IBS, especially IBS-D,2 the subjects under scrutiny by Zhao et al. Second, multiple preclinical studies demonstrate that propionic acid is a potential neurotoxin. Propionic acid can cross the blood-brain barrier and induce inflammation, oxidative stress, mitochondrial dysfunction, while influencing and neurotransmission and gene expression.3 Indeed, propionic acid has been linked to increased anxiety and impairments in typical social behavior among animals.4,5 When paired with emerging research on the neuropsychiatric aspects of propionic acid, and IBS-D, we suggest that Zhao et al have opened up an important area of research, one that might provide a vital link in the complex chain of IBS.

Funding

There is no funding to report.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Zhao J, Li X, Wang X, et al. The value of PHQ-9 and GAD-7 for screening emotional disorders in IBS-D and the specificity of the gut flora associated with emotional comorbidity: preliminary findings. Neuropsychiatr Dis Treat. 2024;20:2145–2158. doi:10.2147/NDT.S486784

2. Ju X, Jiang Z, Ma J, Yang D. Changes in fecal short-chain fatty acids in IBS patients and effects of different interventions: a systematic review and meta-analysis. Nutrients. 2024;16(11):1727. doi:10.3390/nu16111727

3. Abuaish S, Al-Otaibi NM, Aabed K, et al. The efficacy of fecal transplantation and bifidobacterium supplementation in ameliorating propionic acid-induced behavioral and biochemical autistic features in juvenile male rats. J Mol Neurosci. 2022;72(2):372–381. doi:10.1007/s12031-021-01959-8

4. Benitah KC, Kavaliers M, Ossenkopp KP. The enteric metabolite, propionic acid, impairs social behavior and increases anxiety in a rodent ASD model: examining sex differences and the influence of the estrous cycle. Pharmacol Biochem Behav. 2023;231:173630. doi:10.1016/j.pbb.2023.173630

5. Huang L, Duan C, Xia X, et al. Commensal microbe-derived propionic acid mediates juvenile social isolation-induced social deficits and anxiety-like behaviors. Brain Res Bull. 2021;166:161–171. doi:10.1016/j.brainresbull.2020.12.001

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.